AstraZeneca stock falls after FDA panel votes against new cancer drug
--------------------------------------------------------------------
Source: CNBC
Published: 2026-05-01 19:51 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Economy & Finance, Financial Markets, Drugs, Business & Economy
--------------------------------------------------------------------
Snippet:
Shares of AstraZeneca turned lower Friday after U.S. regulatory advisors voted against approving its experimental cancer drug.
--------------------------------------------------------------------